Onderneming Advanced Proteome Therapeutics Corporation
Aandelen
APC.H
CA0076282098
Holdingvennootschappen
Vertraagde tijd
Andere beurzen
|
Variatie 5 dagen | Verschil t.o.v. 1 jan (%) | ||
0,005 CAD | -.--% |
|
-.--% | -.--% |
Vakgebied
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Paul Woodward
CEO | Chief Executive Officer | 63 | 16-04-18 |
Ken Phillippe
DFI | Director of Finance/CFO | 72 | 10-03-09 |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
W. Catalano
BRD | Director/Board Member | 59 | - |
Martin Woodward
BRD | Director/Board Member | 56 | 20-12-18 |
Cory Brandolini
BRD | Director/Board Member | 64 | 21-11-22 |
Paul Woodward
CEO | Chief Executive Officer | 63 | 16-04-18 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 41 127 080 | 36 950 363 ( 89,84 %) | 0 | 89,84 % |
Bedrijfsgegevens
Advanced Proteome Therapeutics Corp.
8337 Eastlake Drive Suite 104
V5A 4W2, Burnaby
+(604) 690-3797
![Adres Advanced Proteome Therapeutics Corporation(APC.H)](https://cdn.zonebourse.com/static/address/58071800.png)
Sector
Vaira. 1 jan. | Kapi. | |
---|---|---|
-.--% | 150K | |
+109,89% | 6,49 mld. | |
+98,02% | 1,25 mld. | |
+2,95% | 990 mln. | |
+26,90% | 830 mln. | |
+2,20% | 667 mln. | |
+3,23% | 626 mln. | |
-.--% | 600 mln. | |
+10,28% | 536 mln. | |
-.--% | 500 mln. |
- Beurs
- Aandelen
- Koers APC.H
- Onderneming Advanced Proteome Therapeutics Corporation